Targeting TLR2 agonists as immunomodulators with broad antiviral activity
Trends in Immunology · 2026-05 · 47 (5) · 354-358
DOI: 10.1016/j.it.2026.03.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Immunology, 2026-05. Verfasst von Nongthombam Boby und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, Karnataka 560012, India. Hauptthemen laut MEDLINE: Toll-Like Receptor 2, Antiviral Agents, Virus Diseases, Immunologic Factors. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Toll-like receptor-2 (TLR2) serves as an innate immune sensor that recognizes specific viral proteins, thereby initiating signaling pathways that can either enhance antiviral host defenses or induce pathological inflammatory responses. In this forum, we discuss the role of TLR2 and its agonists in enhancing antiviral and vaccine-induced immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Developmental Biology and Genetics, Indian Institute of Science, Bengaluru, Karnataka 560012, India.
- Translational Health Engineering Research Center, Michigan Technological University, Grand Rapids, MI 49503, USA. Electronic address: bpahar@mtu.edu.
Zitieren
APA
Boby, N., & Pahar, B. (2026). Targeting TLR2 agonists as immunomodulators with broad antiviral activity. Trends in Immunology, 47(5), 354-358. https://doi.org/10.1016/j.it.2026.03.003
Vancouver
Boby N, Pahar B. Targeting TLR2 agonists as immunomodulators with broad antiviral activity. Trends in Immunology. 2026;47(5):354-358. doi:10.1016/j.it.2026.03.003
BibTeX
@article{Boby2026,
author = {Boby, Nongthombam and Pahar, Bapi},
title = {Targeting TLR2 agonists as immunomodulators with broad antiviral activity},
journal = {Trends in Immunology},
year = {2026},
volume = {47},
number = {5},
pages = {354--358},
doi = {10.1016/j.it.2026.03.003}
}
EUVIMED